IRIDEX Corporation
(NASDAQ: IRIX)

IRIDEX Corporation is a worldwide provider of therapeutic based laser systems, delivery devices and consumable instrumentation used to treat eye diseases in ophthalmology. The Company focuses primarily on its ophthalmology. The Company�s ophthalmology products are sold in the United States predominantly through a direct sales force and internationally through approximately 70 independent distributors into over 100 countries. The Company�s ophthalmology offering include IQ and OcuLight laser systems, consumables and service and support activities. The Company �s family of IQ products includes IQ 532, IQ 577 and IQ 810 laser photocoagulation systems and its OcuLight products include OcuLight TX, OcuLight Symphony (Laser Delivery System), OcuLight SL, OcuLight SLx, OcuLight GL and OcuLight GLx laser photocoagulation systems. In February 2012, The Company sold its aesthetics business to Cutera, Inc.

0.944 s

+0.015 (+1.61%)
Range 0.930 - 0.958   (3.01%)
Open 0.955
Previous Close 0.929
Bid Price 2.350
Bid Volume 9
Ask Price 2.460
Ask Volume 12
Volume 17,698
Value -
Remark s
Delayed prices. Updated at 06 Dec 2025 02:04.
Data powered by
View All Events

About IRIDEX Corp

IRIDEX Corporation is a worldwide provider of therapeutic based laser systems, delivery devices and consumable instrumentation used to treat eye diseases in ophthalmology. The Company focuses primarily on its ophthalmology. The Company�s ophthalmology products are sold in the United States predominantly through a direct sales force and internationally through approximately 70 independent distributors into over 100 countries. The Company�s ophthalmology offering include IQ and OcuLight laser systems, consumables and service and support activities. The Company �s family of IQ products includes IQ 532, IQ 577 and IQ 810 laser photocoagulation systems and its OcuLight products include OcuLight TX, OcuLight Symphony (Laser Delivery System), OcuLight SL, OcuLight SLx, OcuLight GL and OcuLight GLx laser photocoagulation systems. In February 2012, The Company sold its aesthetics business to Cutera, Inc.

Loading Chart...

Please login to view stock data and analysis